Symbicort 160/4.5 mcg Inhaler

Description

Symbicort 160/4.5 mcg Inhaler
(Budesonide/Formoterol Fumarate)

Description:
Symbicort 160/4.5 mcg is a combination inhaler containing budesonide, a corticosteroid, and formoterol fumarate, a long-acting beta-agonist (LABA). This combination works together to control asthma and chronic obstructive pulmonary disease (COPD) symptoms by reducing inflammation and relaxing the airways to improve breathing.

Budesonide is a potent anti-inflammatory agent that works by decreasing inflammation and swelling in the airways, which can lead to improved airflow and reduced symptoms. Formoterol fumarate, a bronchodilator, helps to relax and widen the muscles around the airways, ensuring easier airflow.

Symbicort 160/4.5 mcg is indicated for the maintenance treatment of asthma and COPD, providing effective relief from wheezing, shortness of breath, and coughing. It is designed for twice-daily use and offers rapid and long-lasting relief to help control symptoms throughout the day and night.

Key Features:

• Budesonide: A corticosteroid that works to reduce inflammation and swelling in the airways, helping to control asthma and COPD symptoms over time.
• Formoterol: A long-acting beta-agonist (LABA) that works as a bronchodilator, helping to relax airway muscles, improving airflow, and reducing symptoms like wheezing and shortness of breath.
• Dual Action: This inhaler combines the power of two medications for comprehensive symptom control of both asthma and COPD.
• Twice-Daily Use: Symbicort is typically used twice daily for consistent symptom management, with morning and evening doses providing all-day and all-night relief.
• Easy-to-Use Device: The Symbicort inhaler is a metered-dose inhaler (MDI) that is simple to use, delivering a measured dose of medication with each inhalation.